Read the full press release from BusinessWire here. Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which was expanded to $4 million due to […]